Is Glycopyrrolate Injection in shortage?
Glycopyrrolate Injection is listed by FDA as being discontinued by at least one maker (updated Jul 30, 2026).
Every listed package
FDA tracks shortages per package. What each maker reports, most recently updated first:
- Glycopyrrolate, Injection, .2 mg/1 mL (NDC 63323-578-01)
Discontinuation of the manufacture of the drug
Maker contact: 888-386-1300
- Glycopyrrolate, Injection, 0.4 mg per 2 mL (NDC 63323-578-02)
Discontinuation of the manufacture of the drug
Maker contact: 888-386-1300
- Glycopyrrolate, Injection, 1 mg per 5 mL (NDC 63323-578-05)
Discontinuation of the manufacture of the drug
Maker contact: 888-386-1300
- Glycopyrrolate, Injection, 0.2 mg per 1 mL (NDC 65219-801-01)
Discontinuation of the manufacture of the drug
Maker contact: 888-386-1300
FDA recalls of Glycopyrrolate
Recalls can cause or worsen a shortage. These FDA drug recalls share an active ingredient with Glycopyrrolate Injection:
- NOVADOZ PHARMACEUTICALS LLC recalls Glycopyrrolate Oral Solution, 1 mg/5 mL, 16 oz. (473 mL), Rx only, Manufactured by: MSN Pharmaceuticals Inc.,
- HF Acquisition Co LLC recalls GLYCOPYRROLATE INJECTION, USP 0.2MG/ML, 1mL VIAL, manufactured by HF Acquisition Co. LLC, Mukilteo, WA 98275, NDC
- Aurolife Pharma, LLC recalls Glycopyrrolate Tablets, USP, 1 mg, 100-count bottles, Rx Only, Distributed by: Aurobindo Pharma USA, Inc., East
- Accord Healthcare, Inc. recalls Glycopyrrolate Injection, USP, 0.2 mg/mL, 1 mL Single Dose Vial x 25 vials, Rx Only, Manufactured for: Accord
- Accord Healthcare, Inc. recalls Glycopyrrolate Injection, USP, 0.4 mg/2 mL (0.2 mg/mL) 2 mL Single Dose Vial X 25 vials carton, Rx Only, Manufactured
- Accord Healthcare, Inc. recalls Glycopyrrolate Injection, USP 4 mg/20 mL (0.2 mg/mL) 20 mL Multiple Dose Vial, 10vial carton, Rx Only, Manufactured
- Accord Healthcare, Inc. recalls Glycopyrrolate Injection, USP 1 mg/5 mL (0.2 mg/mL) 5 mL Multiple Dose Vial, x 10 vials carton, Rx Only, Manufactured
- AVKARE LLC recalls Glycopyrrolate Tablets, USP, 1 mg, 50 Tablets (5x10) Unit Dose carton, Rx Only, Manufactured for: AvKARE Pulaski, TN
- Aurolife Pharma, LLC recalls Glycopyrrolate Tablets, USP, 1 mg, 100 tablets, Rx Only, Distributed by: Aurobindo Pharma USA, Inc., East Windsor, NJ
- Aurolife Pharma, LLC recalls Glycopyrrolate Tablets, USP, 1 mg, 100-count bottle, Rx Only, Distributed by: Aurobindo Pharma USA, Inc., 279
- Cardinal Health Inc. recalls Bevespi Aerosphere (glycopyrrolate and formoterol fumarate) Inhalation Aerosol 9 mcg/4.8 mcg per inhalation For Oral
- Accord Healthcare, Inc. recalls Glycopyrrolate Injection, USP 0.4 mg/2 mL (0.2 mg/mL) 25 x 2 mL Single Dose Vials Rx Only, Manufactured for: Accord
Glycopyrrolate Injection shortage questions
Is Glycopyrrolate Injection in shortage?
Glycopyrrolate Injection is listed by FDA as being discontinued by at least one maker (updated Jul 30, 2026).
What should I do if I can’t get Glycopyrrolate Injection?
Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.
Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.